153 related articles for article (PubMed ID: 15359947)
1. [Hyperkalemia. Main symptoms: muscle weakness, cardiac arrhythmias].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Jul; 93(29-30):1177-82, 1216. PubMed ID: 15359947
[No Abstract] [Full Text] [Related]
2. Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001.
Fleming T; Borer J; Lipicky R; Armstrong PW
Circulation; 2001 Oct; 104(18):E9039. PubMed ID: 11684648
[No Abstract] [Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
4. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
[No Abstract] [Full Text] [Related]
5. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
[No Abstract] [Full Text] [Related]
6. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases].
Sänchez Torres G; Posadas C; Boyer JL; Guzmán Lara J; Serrano P
Arch Inst Cardiol Mex; 1981; 51(3):233-40. PubMed ID: 6456707
[No Abstract] [Full Text] [Related]
7. Valsartan in chronic heart failure.
Haddy FJ
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11948282
[No Abstract] [Full Text] [Related]
8. Life-threatening, preventable hyperkalemia in a nursing home resident: case report and literature review.
Dharmarajan TS; Nguyen T; Russell RO
J Am Med Dir Assoc; 2005; 6(6):400-5. PubMed ID: 16286062
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone.
Fujii H; Nakahama H; Yoshihara F; Nakamura S; Inenaga T; Kawano Y
Kobe J Med Sci; 2005; 51(1-2):1-6. PubMed ID: 16199929
[TBL] [Abstract][Full Text] [Related]
10. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Fuster D; Frey FJ; Ferrari P
Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
[TBL] [Abstract][Full Text] [Related]
11. Potassium disturbances and associated electrocardiogram changes.
Humphreys M
Emerg Nurse; 2007 Sep; 15(5):28-34. PubMed ID: 17902552
[TBL] [Abstract][Full Text] [Related]
12. [What comes to mind with this ECG?].
Simonis G
MMW Fortschr Med; 2007 Jun; 149(25-26):5. PubMed ID: 17713039
[No Abstract] [Full Text] [Related]
13. BP drug approved for heart failure.
Health News; 2002 Oct; 8(10):9. PubMed ID: 12416491
[No Abstract] [Full Text] [Related]
14. Valsartan for hypertension.
Med Lett Drugs Ther; 1997 Apr; 39(999):43-4. PubMed ID: 9137296
[No Abstract] [Full Text] [Related]
15. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225
[No Abstract] [Full Text] [Related]
16. [New combination of high dosage sartan and 25 mg HCT. Systolic blood pressure lowered by 21 mmHg].
MMW Fortschr Med; 2004 Apr; 146(15):68. PubMed ID: 15373029
[No Abstract] [Full Text] [Related]
17. [AT1 receptor antagonists in treatment of hypertension].
Franz IW
Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581
[No Abstract] [Full Text] [Related]
18. [Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer].
Unger T
Fortschr Med; 1997 Aug; 115(24):42-3. PubMed ID: 9410822
[No Abstract] [Full Text] [Related]
19. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
Erden I; Yalcin S; Ozhan H
Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
[TBL] [Abstract][Full Text] [Related]
20. Hyperkalemic cardiac arrhythmia secondary to spironolactone.
Pongpaew C; Songkhla RN; Kozam RL
Chest; 1973 Jun; 63(6):1023-5. PubMed ID: 4711847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
